medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 6

Ann Hepatol 2017; 16 (6)

The Optimal Transfusion Strategy in Liver Transplantation: The Quest Continues

Intagliata NM, Northup PG, Caldwell SH
Full text How to cite this article

Language: English
References: 9
Page: 828-829
PDF size: 117.09 Kb.


Key words:

No keywords

Text Extraction

Smart, et al. Rotational Thromboelastometry or Conventional Coagulation Tests in Liver Transplantation: Comparing Blood Loss, Transfusions, and Cost. Annals of Hepatology.

The physiology of hemostasis in decompensated cirrhosis is profoundly distinct from any other disease state encountered during surgery. Our current understanding of the coagulation system in cirrhosis has expanded significantly over the last 15 years. This new paradigm relies entirely on the concept of a rebalanced coagulation state, where all of the components of the system are significantly altered (both pro and anticoagulant portions), but maintained in a precarious equilibrium. External disruption of this balance, whether a consequence of disease progression or from human intervention, can thrust the balance into bleeding or thrombosis, often in dramatic fashion. Liver transplantation represents one of the greatest physiological insults to this balance. In the perioperative period, both bleeding or thrombosis can be catastrophic, which imbues a strong impulse to aim all measures at prevention. However, without an adequate measure to provide guidance, current efforts at prophylactic therapy are often misguided and potentially counter-productive. Particularly transfusion of large volumes of blood product (excessive use of fresh frozen plasma (FFP)) can only serve to potentiate portal hypertension and beget a vicious cycle of bleeding.


REFERENCES

  1. Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 2013; 11: 1064-74.

  2. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147-56.

  3. Massicotte L, Perrault MA, Denault AY, Klinck JR, Beaulieu D, Roy JD, Thibeault L, et al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation 2010; 89: 920-7.

  4. Zimmon DS, Kessler RE. The portal pressure- blood volume relationship in cirrhosis. Gut 1974; 15: 99-101.

  5. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 388-93.

  6. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BWJr, Starzl TE, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888-96.

  7. Blasi A, Beltran J, Pereira A, Martinez-Palli G, Torrents A, Balust J, Zavala E, et al. An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion 2012; 52: 1989-98.

  8. Roullet S, Freyburger G, Cruc M, Quinart A, Stecken L, Audy M, Chiche L, et al. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm. Liver Transpl 2015; 21: 169-79.

  9. Intagliata NM, Caldwell SH, Porte RJ, Lisman T. Prediction of bleeding in cirrhosis patients: Is the forecast any clearer? Hepatology 2016; 64: 989-90.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Ann Hepatol. 2017;16